DGDA: Use of antibiotics restricted for coronavirus treatment
28 March 2020
DGDA Director General (DG) Maj Gen Md Mahbubur Rahman said this at a press conference in Dhaka on Monday morning.
At the press conference, Delta Pharma Ltd announced to provide 300,000 necessary medicines (tablets) to treat Covid-19 patients. The medicines include Hydroxychloroquine and Azithromycin.
The director general said 100,000 tablets can be used for 20,000 coronavirus affected patients.
Apart from Delta Pharma, other pharmaceutical companies are also ready to supply medicines, he added
Further reading: Dhaka Tribune
Author(s): Dhaka Tribune
Healthy Patients
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Global Ambassador Network
Welcome at the AMR Insights Ambassador Network!
The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).
